(Q40289575)

19 September 2017

title

Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53. (English)

1 reference

19 September 2017

1 reference

4

Swisher SG

1 reference

19 September 2017

2

Fanale MA

1 reference

19 September 2017

Pataer A

1

1 reference

19 September 2017

Roth JA

series ordinal

3

1 reference

19 September 2017

Hunt KK

series ordinal

5

1 reference

19 September 2017

publication date

21 April 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

13

1 reference

19 September 2017

issue

8

1 reference

19 September 2017

page(s)

806-814

1 reference

Apoptosis in the pathogenesis and treatment of disease

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

Alternative splicing of Bcl-2-related genes: functional consequences and potential therapeutic applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

Impact of proapoptotic proteins Bax and Bak in tumor progression and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

21 January 2018

p53: good cop/bad cop.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

Enhanced gene transfer and cell death following p53 gene transfer using photochemical internalisation of glucosylated PEI-DNA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

Amifostine cytotoxicity and induction of apoptosis in a human myelodysplastic cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

Amifostine inhibits angiogenesis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

Inhibition of spontaneous metastases formation by amifostine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

The cytoprotective aminothiol WR1065 activates p21waf-1 and down regulates cell cycle progression through a p53-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

p53 protein regulates the effects of amifostine on apoptosis, cell cycle progression, and cytoprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

Cytoprotection by WR-1065, the active form of amifostine, is independent of p53 status in human malignant glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

Selective activation of oncogenic Ha-ras-induced apoptosis in NIH/3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

Premature p34cdc2 activation required for apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

Activation-induced T-cell death is cell cycle dependent and regulated by cyclin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

Checkpoint on the nuclear frontier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

7 January 2021

Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

7 January 2021

Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

7 January 2021

p34cdc2 and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

7 January 2021

Induction of p21(CIP1/Waf1) and activation of p34(cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

7 January 2021

Transient tyrosine phosphorylation of p34cdc2 is an early event in radiation-induced apoptosis of prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

7 January 2021

Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

7 January 2021

Transcriptional activation of the cdc2 gene is associated with Fas-induced apoptosis of human hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700960

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700960

1 reference

Dimensions Publication ID

19 September 2017

1018277432

0 references

1 reference